Turning Cell Signaling against Cancer
Researchers Use Single-Molecule Assays, Splice-Switching Oligonucleotides, and Fusion Constructs
Literature Review: Defending against Virus, with a Little Help from Microbiome
A Specific Human-Associated Gut Microbe Produced DAT and Rescued Antibiotic-Treated Influenza-Infected Mice
Novel Viral Vectors for Gene Therapy
Synthetic Viral Vectors Show Promise for Mitigating Immune Response to Gene Therapy
Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Gene Therapy Allows Hemophilia Patients to Give Up Medication, Avoid Bleeds; but More Improvements Are Needed
Patricia Greenhalgh Ph.D.
Patricia Greenhalgh, Ph.D., is R&D manager in virology and microbiological sciences, processing technologies at MilliporeSigma.